Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by xodcodeon Dec 19, 2020 10:10am

401 Views

Post# 32146769

TLT News

TLT research is moving forward slowly but surely. Recent results set the stage for significant price increments in 2021 propelled by positive phase 2 testing.

Bought some more shares yesterday at $0.195,

Recent TLT price uptrend suugests (to me) that sub $0.20 pricing may soon be a thing of the past.

Looking for $0.30 within next 4 months.

Bullboard Posts

Day trading vs. swing trading strategies for small-cap stocks